CCG-257081 - AN OVERVIEW

g. IPF and scleroderma), even so the pathophysiology of these styles, depending on immediate administration of drug to tissue, differs considerably from scientific bleomycin‐induced lung fibrosis. Alternatively, systemic administration of a pro‐fibrotic drug like bleomycin need to more closely mimic the inflammatory and fibrotic processes viewe